Ophthalmologic Drug Guide
By: Rhee, Douglas J [author.].
Contributor(s): Colby, Kathryn A [author.] | Rapuano, Christopher J [author.] | Sobrin, Lucia [author.] | SpringerLink (Online service).
Material type:
BookPublisher: New York, NY : Springer New York, 2007.Description: XII, 142 p. online resource.Content type: text Media type: computer Carrier type: online resourceISBN: 9780387499642.Subject(s): Medicine | Ophthalmology | Medicine & Public Health | OphthalmologyDDC classification: 617.7 Online resources: Click here to access online | Item type | Current location | Call number | Status | Date due | Barcode | Item holds |
|---|---|---|---|---|---|---|
E books
|
PK Kelkar Library, IIT Kanpur | Available | EBK3529 |
Antibacterial Agents -- Antifungal Agents -- Antiviral Agents -- Antiparasitic Agents -- Antiglaucoma Agents -- Neuro-Ophthalmology -- Anti-Inflammatory Agents -- Mydriatics, Cycloplegics, and Reversal Agents -- Lubricants and Viscoelastics -- Miscellaneous Conditions -- Anti-Angiogenesis Agents -- Contact Lens Solutions.
Ophthalmology has long been considered a surgical area because so many disorders/diseases are treated surgically rather than medically. In the past ten years, however, there have been considerable therapeutic breakthroughs in non-surgical treatments. For instance, anti-glaucoma agents have becoming increasingly effective. This edition will include a new chapter for retinal disease. There are now several pharmaceutical agents being used to treat these diseases. Specifically, age-related macular degeneration has many new products – macugen, lucentis, etc. – and intraocular infections are primarily treated with intravitreal medications. Additionally, the anti-allergy and dry eye markets have grown tremendously in the last 2-3 years (endura, restasis, xibrom, etc).
There are no comments for this item.